Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Päivi Rahkola‐Soisalo"'
Publikováno v:
Investigative and Clinical Urology, Vol 60, Iss 2, Pp 114-119 (2019)
Purpose: Mirabegron, a β3-adrenoreceptor agonist, is used to treat overactive bladder. The factors affecting persistence of mirabegron use or symptom improvement are not thoroughly known, but could be related to patient characteristics. Therefore, w
Externí odkaz:
https://doaj.org/article/d407755468fc405bb76da4cba591e8ee
Autor:
Sari Tulokas, Maarit Mentula, Päivi Härkki, Tea Brummer, Tea Kuittinen, Tomi Mikkola, Päivi Rahkola-Soisalo
Publikováno v:
Archives of Gynecology and Obstetrics. 306:2069-2075
Purpose Hysterectomy and mid-urethral sling (MUS) are common operations, but little is known about how hysterectomy after MUS affects the risk for stress urinary incontinence (SUI) relapse. Methods We included 49 women with a MUS before hysterectomy
Autor:
Tea Kuittinen, Sari Tulokas, Päivi Rahkola‐Soisalo, Tea Brummer, Jyrki Jalkanen, Eija Tomas, Juha Mäkinen, Jari Sjöberg, Päivi Härkki, Maarit Mentula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d2caf64752d0f917b14857ce1c0b9ac
http://hdl.handle.net/10138/357702
http://hdl.handle.net/10138/357702
Autor:
Anna-Maija Itkonen Freitas, Camilla Isaksson, Päivi Rahkola-Soisalo, Sari Tulokas, Maarit Mentula, Tomi S. Mikkola
Publikováno v:
The Journal of urology. 208(3)
PURPOSE: We sought to determine whether polyacrylamide hydrogel (PAHG) is noninferior to tension-free vaginal tape (TVT) in the treatment of women with primary stress urinary incontinence (SUI). MATERIALS AND METHODS: In this noninferiority trial, 22
Autor:
Päivi Rahkola-Soisalo, Sari Tulokas, Anna-Maija Itkonen Freitas, Tomi S. Mikkola, Maarit Mentula
Publikováno v:
International Urogynecology Journal
Introduction and hypothesis To assess changes in quality of life (QoL) and sexual function outcomes at 1 year after tension-free vaginal tape (TVT) versus polyacrylamide hydrogel injection (PAHG). Methods In a randomized trial comparing TVT (n = 111)
Publikováno v:
International Urogynecology Journal
Introduction and hypotheses There is no consensus regarding pregnancy after mid-urethral sling (MUS) operation, and some clinicians recommend postponing the MUS operation if a woman considers further pregnancies or routinely suggest cesarean section
Autor:
Päivi Rahkola-Soisalo, Hanna Savolainen-Peltonen, Olavi Ylikorkala, Fabian Hoti, Mika Gissler, Tomi S. Mikkola, Pia Vattulainen
Publikováno v:
Menopause. 26:140-144
OBJECTIVE Receptors for estrogen and progesterone are present in the pelvic floor, and therefore, postmenopausal hormone therapy may affect its function. We compared the former use of estradiol-progestogen postmenopausal hormone therapy in nonhystere
Autor:
Tomi S. Mikkola, Edward Morcos, Christian Falconer, Daniel Altman, Päivi Rahkola-Soisalo, Georgios Poutakidis
Publikováno v:
Archives of Gynecology and Obstetrics
Purpose The aim of this study was to compare long-term effects of high-volume surgery at a single-center to multicenter use when using a mesh-capturing device for pelvic organ prolapse (POP) repair. Methods Five years after surgery 101 (88%) at the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3a4279fdf0340d579d00cadd0eb3c2c
http://hdl.handle.net/10138/325907
http://hdl.handle.net/10138/325907
Introduction and hypothesis Long-term safety concerns have risen over the mid-urethral sling operation (MUS) for stress urinary incontinence (SUI), which in some countries has led to litigations and even suspending MUS insertions. We examined the lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca24125c173bedbae962ad2e63778d96
http://hdl.handle.net/10138/325148
http://hdl.handle.net/10138/325148
Autor:
Päivi Rahkola-Soisalo, Mika Gissler, Hanna Savolainen-Peltonen, Fabian Hoti, Tomi S. Mikkola, Olavi Ylikorkala, Pia Vattulainen
Publikováno v:
International Urogynecology Journal. 30:251-256
Introduction and hypothesisThe impact of estradiol-based hormone therapy (HT) on the incidence of stress urinary incontinence (SUI) is unknown. Therefore, we compared the use of such HT regimens and tibolone in women with and without SUI.MethodsThe w